BOIMMG

1-(13Z-docosenoyl)-2-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

BOIMMG ID - 264782

Name - 1-(13Z-docosenoyl)-2-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3,4,5-trisphosphate

SMILES - CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCCCCCCCCCCCC(=O)O[C@H](COC(=O)CCCCCCCCCCC/C=C\CCCCCCCC)COP(=O)([O-])O[C@@H]1[C@H](O)[C@H](OP(=O)([O-])[O-])[C@@H](OP(=O)([O-])[O-])[C@H](OP(=O)([O-])[O-])[C@H]1O

InChIKey - WTPLSHAMFGGOPU-GWZLQOQQSA-G

Formula - C63H107O22P4

Annotated - ✔

SWISS LIPIDS id - SLM:000440260

+Structural Parent

+Precursors

+Components

Lipid name	Formula	BOIMMG ID	Listed
1-(13Z-docosenoyl)-2-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4,5-bisphosphate	C63H108O19P3	289125	✔
1-(13Z-docosenoyl)-2-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-4-phosphate	C63H109O16P2	278481	✔
1-(13Z-docosenoyl)-2-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol	C63H110O13P	11369	✔
CDP-1-(13Z-docosenoyl)-2-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycerol	C66H111N3O15P2	551668	✔
1-(13Z-docosenoyl)-2-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycero-3-phospho-1D-myo-inositol-3-phosphate	C63H109O16P2	266015	✔
1-(13Z-docosenoyl)-2-(17Z,20Z,23Z,26Z,29Z-dotriacontapentaenoyl)-sn-glycero-3-phosphate	C57H99O8P	18701	✔
Acyl-ACP ((17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoate)	C32H53OSR1	749623	✗
1-(13Z-docosenoyl)-sn-glycero-3-phosphate	C25H47O7P	6816	✔
(17Z,20Z,23Z,26Z,29Z)-dotriacontapentaenoyl-CoA	C53H84N7O17P3S	364	✔
Acyl-ACP ((13Z)-docosenoate)	C22H41OSR1	749048	✗
Acyl-Phosphates ((13Z)-docosenoate)	C22H43O5P	738929	✗